Corcept Therapeutics's total assets for Q1 2025 were $846.46M, an increase of 0.70% from the previous quarter. CORT total liabilities were $163.17M for the fiscal quarter, a 1.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.